Genotyping is increasingly used to study genetic makeup and variation
in the genotypes of various living organisms, such as humans, plants,
and animal, including microorganism. Genotyping tests are extensively
used in various development processes of drug discovery and in
providing personalized therapies to treat a host of genetic
diseases.
There is an increasing demand for various genotyping analysis
services across developed and developing regions. This is expected to
lower the cost of these services so that it falls within the ambit of
average citizens. The enhanced proclivity to understand the genetic
make-up to understand the causes of different diseases such as
diabetes, cardiovascular ailments, and cancer, as well as the urge to
know the physical build have led to the wide demand for these
genotyping analysis services across the globe.
The report provides in-depth insights into the key drivers and
restraints, emerging trends and opportunities, market share and size
of key segments, and competitive dynamics. The research study
provides analysis of the factors affecting the demand for genotyping
analysis services in various regions. The initiatives taken by
various biotech and healthcare companies to capitalize on the
lucrative avenues in emerging market are evaluated in the report. The
study takes a closer look at the investments trends in major
countries and makes an assessment of the impact of key technological
advancements on the strategic landscape.
The increasing incidence of genetic diseases, rapidly emerging demand
for personalized medicines, price reduction of DNA sequencing, and
intensive researches in genes and gene variants associated with rare
diseases are the key factors driving the global genotyping analysis
services market. In addition, increased application of single
nucleotide polymorphisms (SNP) genotyping in drug development and
genotyping of animal and plant livestock is aiding the market’s
expansion. The growing demand for genotyping services from
pharmacogenomics, diagnostic researches, and animal breeding is
driving the market.
Genotyping of viruses or bacteria can be a useful tool in tracing the
origin of diseases outbreak and controlling their spread. Intensive
interest in personalized genomic analysis among the scientific
fraternity and increased focus of various biotech and healthcare
companies toward the discovery of personalized therapies are expected
to fuel the steady growth of the market along the forecast period.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2441
A spate of advanced technologies in genotyping analysis that allows
researchers to make multiplex and parallel analysis of biological
systems at all levels—cells, protein, and gene level-facilitates
assessing a person’s risk of developing a rare disease. However,
owing to substantial costs associated with whole-genome sequencing of
any organism, genotyping of rare variants has emerged as a key
challenge hindering the growth of the market to an extent.
Nevertheless, development of microarrays that are cost-effective and
have higher-throughput will open exciting opportunities for the
market players in various regions.
North America is a prominent market for the genotyping analysis
services. The significant growth in the regional market is attributed
to an advanced healthcare infrastructure, rapid advances in genetic
engineering, and high demand for services related to genetic testing.
In addition, the soaring demand for personalized therapies is
expected to boost the market over the forecast period.
Asia Pacific region is expected to rise at an impressive CAGR along
the forecast period. Rise in various healthcare reforms, increasing
discretionary spending on healthcare, and the large presence of
untapped opportunities have bolstered the demand for genotyping
analysis services in Asia Pacific.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=2441
Several companies provide a diverse portfolio of genotyping analysis
services such as human whole genome sequencing, microarray services,
long-read sequencing services, and certified service provider
programs to generate significant revenue. Key market players are
opting for mergers and acquisitions to increase their market shares.
Some of the major companies operating in the genotyping analysis
services market include Illumina, Inc., Affymetrix, Inc., Fluidigm,
Harlan Laboratories, Sequenome, Roche Diagnostics, and Life
Technologies.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment